Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro

por Raymonda, M.H., Ciesla, J.H., Monaghan, M., Leach, J., Asantewaa, G., Smorodintsev-Schiller, L.A., Lutz, M.M., Schafer, X.L., Takimoto, T., Dewhurst, S., Munger, J., Harris, I.S.
Publicado 2022